Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Having -c- – wherein x is chalcogen – bonded directly to...
Patent
1993-04-01
1995-01-31
Richter, Johann
Drug, bio-affecting and body treating compositions
Designated organic active ingredient containing
Having -c-, wherein x is chalcogen, bonded directly to...
514934, 546112, 546138, 546183, A61K 3144, G07D21146
Patent
active
053859111
ABSTRACT:
Certain Castanospermine ester derivatives of the formula: ##STR1## wherein R, R.sub.1 and R.sub.2 are each independently hydrogen, C.sub.1-14 alkanoyl, C.sub.1-14 alkenoyl, cyclohexanecarbonyl, C.sub.1-8 alkoxyacetyl, ##STR2## naphthalenecarbonyl optionally substituted by methyl or halogen; phenyl (C.sub.2-6 alkanoyl) wherein the phenyl is optionally substituted by methyl or halogen; cinnamoyl; pyridinecarbonyl optionally substituted by methyl or halogen; dihydropyridine carbonyl optionally substituted by C.sub.1 -C.sub.10 alkyl; thiophenecarbonyl optionally substituted by methyl or halogen; or furancarbonyl optionally substituted by methyl or halogen; Y is hydrogen, C.sub.1-4 alkyl, C.sub.1-4 alkoxy, halogen, trifluoromethyl, C.sub.1-4 alkylsulfonyl, C.sub.1-4 alkylmercapto, cyano or dimethylamino; Y' is hydrogen, C.sub.1-4 alkyl, C.sub.1-4 alkoxy, halogen or it is combined with Y to give 3,4-methylenedioxy; Y" is hydrogen, C.sub.1-4 alkyl, C.sub.1-4 alkoxy or halogen; with R, R.sub.1 and R.sub.2 being selected in such a way that at least one of them, but not more than two of them, is hydrogen; are disclosed to be effective in treating diseases caused by Herpes Simplex Virus (HSV) Types 1 and 2.
REFERENCES:
patent: 4751236 (1988-06-01), Mishniot et al.
patent: 4757088 (1988-07-01), Haines et al.
patent: 4760079 (1988-07-01), Baldone
patent: 4782065 (1988-11-01), Albrecht et al.
patent: 4800081 (1989-01-01), Albrecht et al.
patent: 5004746 (1991-04-01), Liu et al.
patent: 5017563 (1991-05-01), Liu et al.
Taylor, et al., Antiviral Research, vol. 10(1-3):11-26 (Nov. 1988).
Montalvo, et al., J. of Virology, vol. 61(9):2877-2884 (Sep. 1987).
Schlesinger, et al., Virus Research, vol. 2(2):139-149 (Mar. 1985).
Schulhafer, et al., In Vivo, vol. 3(2):61-78 (1989).
Liu, et al., Tetrahedron Letters, vol. 31(20):2829-2832 (1990).
The Merck Manual of Diagnosis and Therapy, 1987, R. Berkow, et al. (eds), pp. 180-183, Merck & Co., Inc., Rahway, N.J.
Hohenschutz, et al., Chem Abs. 95(23), 204246f, Dec. 7, 1981.
Dreyer, D. L., et al., J. Chem. Ecol., 11(8), 1045-51 (1985).
Campbell, Chem. Abs. 107(23), 215128m, Dec. 7, 1987.
Sunkara, P. S., et al. Society for Complex Carbohydrates, 17th Annual Mtg., San Antonio, Texas, Glycosidse inhibitors as Antivirals Against Human Immunodeficiency Virus (HIV) (1986).
Armstrong, Sue, Tree Compounds May Strip the Virus of Its Powers, New Scientist No. 1640, p. 23, 1988.
Saul et al., Chem Abs. 102(15), 126770u, Apr. 15, 1985.
Saul et al., Chem Abs. 98(17), 139631y, Apr. 25, 1983.
Palmarczyk, Chem. Abs. 103(3), 20519z, Jul. 22, 1985.
Chambers, J. P. Chem. Abs. 105(15), 129836t, Oct. 13, 1986.
Fiumara, Nicholas; Herpes Simplex, Varicella, and Herpes Zoster (Upjohn Pamphlet), pp. 8-28 (1986).
Fiumara, Nicholas, Herpes Simplex, Varicella, and Herpes Zoster, (Upjohn Pamphlet). (1987).
Hiroyuki, et al., Chem Abs. 105(3), 24481v, Jul. 21, 1986.
Bernotas, et al, Chem Abs. 100(23), 192129b, Jun. 4, 1984.
Hohenschutz, et al., Phytochemistry, vol. 20(4):811-814 (1981).
Liu Paul S.
Sunkara Sai P.
Taylor Debra L.
Tyms A. Stanley
Collier Kenneth J.
Kilby Scalzo Catherine S.
Merrell Dow Pharmaceuticals Inc.
Richter Johann
LandOfFree
Anti-herpes castanospermine esters does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Anti-herpes castanospermine esters, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Anti-herpes castanospermine esters will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-1102378